Transarterial Embolization Enhances Programmed Cell Death Ligand 1 Expression and Influences CD8 + T Lymphocytes Cytotoxicity in an Orthotopic Hepatocellular Carcinoma Rat Model.

MLA

Zhang, Shen, et al. “Transarterial Embolization Enhances Programmed Cell Death Ligand 1 Expression and Influences CD8 + T Lymphocytes Cytotoxicity in an Orthotopic Hepatocellular Carcinoma Rat Model.” Cardiovascular and Interventional Radiology, vol. 47, no. 10, Oct. 2024, pp. 1372–81. EBSCOhost, https://doi.org/10.1007/s00270-024-03813-x.

APA

Zhang, S., Xu, L., Li, J.-Q., Du, M.-Z., Yin, Y., Zhong, B.-Y., Liang, H.-S., Li, W.-C., Ni, C.-F., & Zhu, X.-L. (2024). Transarterial Embolization Enhances Programmed Cell Death Ligand 1 Expression and Influences CD8 + T Lymphocytes Cytotoxicity in an Orthotopic Hepatocellular Carcinoma Rat Model. Cardiovascular and Interventional Radiology, 47(10), 1372–1381. https://doi.org/10.1007/s00270-024-03813-x

Chicago

Zhang, Shen, Lin Xu, Jia-Qing Li, Ming-Zhan Du, Yu Yin, Bin-Yan Zhong, Han-Si Liang, Wan-Ci Li, Cai-Fang Ni, and Xiao-Li Zhu. 2024. “Transarterial Embolization Enhances Programmed Cell Death Ligand 1 Expression and Influences CD8 + T Lymphocytes Cytotoxicity in an Orthotopic Hepatocellular Carcinoma Rat Model.” Cardiovascular and Interventional Radiology 47 (10): 1372–81. doi:10.1007/s00270-024-03813-x.